<?xml version="1.0" encoding="UTF-8"?>
<p id="Par1547">
 <bold>Conclusions:</bold> Teicoplanin should be considered as an effective alternative to vancomycin in Methicillin-resistant staphylococcus aureus (MRSA) infections treatment. Adverse effects such as nephrotoxicity and bicytopeniasignificantly were decreased in teicoplanin therapy.
</p>
